Cold & Cough Remedies - D-A-CH

  • D-A-CH
  • In 2024, the Cold & Cough Remedies market market in the D-A-CH region, consisting of Germany, Austria, and Switzerland, generates a revenue of US$2.59bn.
  • It is projected to experience an annual growth rate of 4.77% (CAGR 2024-2029).
  • When compared globally, the in the United States leads the market with a revenue of US$11,190.00m in 2024.
  • Taking into account the population figures, the per person revenue in the D-A-CH region amounts to US$25.66 in 2024.
  • Germany's cold and cough remedies market is driven by a strong demand for natural and herbal products.

Key regions: United States, Japan, Australia, United Kingdom, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in D-A-CH has been experiencing steady growth in recent years, driven by customer preferences for over-the-counter remedies and the increasing prevalence of cold and cough symptoms. Customer preferences in the D-A-CH region have shifted towards self-medication and over-the-counter remedies for cold and cough symptoms. This can be attributed to the convenience of purchasing these remedies without a prescription and the desire for immediate relief. Consumers are increasingly looking for products that provide quick and effective relief from symptoms such as congestion, sore throat, and cough. As a result, there has been a growing demand for cough syrups, decongestants, and throat lozenges in the market.Trends in the market indicate that there is a growing focus on natural and herbal remedies for cold and cough symptoms. Consumers are becoming more conscious of the ingredients in the products they use and are seeking natural alternatives to traditional medications. This trend is driven by the perception that natural remedies are safer and have fewer side effects. As a result, there has been an increase in the availability and popularity of herbal cough syrups, herbal throat lozenges, and natural decongestants in the D-A-CH market.Local special circumstances in the D-A-CH region also contribute to the development of the Cold & Cough Remedies market. The region experiences cold winters and a high prevalence of respiratory infections, leading to an increased demand for remedies to alleviate cold and cough symptoms. Additionally, the D-A-CH region has a well-developed healthcare system and a high level of healthcare awareness among the population. This creates a conducive environment for the growth of the Cold & Cough Remedies market, as consumers are more likely to seek treatment for their symptoms and are willing to invest in over-the-counter remedies.Underlying macroeconomic factors also play a role in the development of the Cold & Cough Remedies market in D-A-CH. The region has a stable economy and a high standard of living, which allows consumers to afford and prioritize their health and well-being. Additionally, the aging population in D-A-CH is more susceptible to cold and cough symptoms, leading to a higher demand for remedies in this demographic. The increasing prevalence of cold and cough symptoms, coupled with the favorable economic conditions, contribute to the growth of the Cold & Cough Remedies market in D-A-CH.In conclusion, the Cold & Cough Remedies market in D-A-CH is developing due to customer preferences for over-the-counter remedies, the growing focus on natural and herbal remedies, local special circumstances such as cold winters and a high prevalence of respiratory infections, and underlying macroeconomic factors such as a stable economy and an aging population.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)